Novartis Institute for Tropical Diseases (NITD)
The Novartis Institute for Tropical Diseases (NITD) is a small-molecule drug discovery research institute working on new treatments and prevention methods for dengue, tuberculosis and malaria.
News
Dr. Manos Perros named Director of the Novartis Institute for Tropical Diseases
Basel, December 11, 2009
2nd International NEHCRI Tuberculosis and Dengue Symposium
Makassar, Indonesia, October 19, 2009
NITD Dengue Symposium
Philippines, September 1-3, 2009
Making drugs accessible to poor populations: a funding model
Global Forum Update on Research for Health Volume 5, Fostering innovation for global health, by Paul Herrling.
Download the PDF
(620 KB)
NIH-NITD Dengue workshop
Discovery and Evaluation of Therapeutics against Dengue, NITD, Singapore, April 23-24, 2008.
Download the PDF
(81 KB)
Dengue Digest 2009
Read update about dengue research: Dengue Digest Vol 6 No 1
(2.2 MB)
Dengue Digest 2008
Read update about dengue research: Dengue Digest Vol 5 No 1
(1.19 MB)
Dengue Digest 2007
Read update about dengue research: Dengue Digest Vol 4 No 1
(663 KB)
Read update about dengue research: Dengue Digest Vol 4 No 2
(544 KB)
Corporate Citizenship
Corporate citizenship at Novartis is an integral part of how we operate and a key to our success.
Event calendar
Find out about upcoming events for shareholders.